Discover

PHAT
Phathom Pharmaceuticals, Inc.
10.54
2 x 7.85
2 x 13.44
bid
ask
-
0.31
2.90%
2 @ 07:03 AM
10.69 +0.15 (1.47%)
Ytd-36.50%
1y18.24%
10.42
day range
11.01
7.61
52 week range
18.31
Open10.85Prev Close10.85Low10.42High11.01Mkt Cap840.23M
Vol901.34KAvg Vol1.19MEPS-2.09P/EN/AForward P/E7.60
Beta0.61Short Ratio9.36Inst. Own83.10%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning04-3050-d Avg11.16200-d Avg12.701yr Est23.70

PHAT News

benzinga.com
Phathom Pharmaceuticals Completes Patient Enrollment In Its Phase 2 pHalcon-EoE-201 Clinical Study O

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and c

benzinga.com
HC Wainwright & Co. Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT)

Phathom Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript
benzinga.com
Phathom Pharmaceuticals Reports Q1 2026 Results: Full Earnings Call Transcript

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

benzinga.com
Phathom Pharmaceuticals Affirms FY2026 Sales Guidance of $320.000M-$345.000M vs $331.417M Est

Phathom Pharmaceuticals (NASDAQ:PHAT) affirms FY2026 sales outlook from $320.000 million-$345.000 mi

benzinga.com
Phathom Pharmaceuticals Q1 Adj. EPS $(0.18) Beats $(0.32) Estimate, Sales $58.301M Beat $57.028M Est

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.18) per share which beat the

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

This Argan Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
benzinga.com
This Argan Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

Top Wall Street analysts upgraded PHAT and PWR, while AGX was upgraded to Overweight with a $550 pri

benzinga.com
Barclays Upgrades Phathom Pharmaceuticals to Overweight, Raises Price Target to $18

Barclays analyst Glen Santangelo upgrades Phathom Pharmaceuticals (NASDAQ:PHAT) from Equal-Weight

benzinga.com
Guggenheim Maintains Buy on Phathom Pharmaceuticals, Raises Price Target to $25

Guggenheim analyst Yatin Suneja maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and ra

benzinga.com
Phathom Pharmaceuticals Sees FY2026 Sales $320.000M-$345.000M vs $314.481M Est

Phathom Pharmaceuticals (NASDAQ:PHAT) sees FY2026 sales of $320.000 million-$345.000 million vs $314

Phathom Pharmaceuticals Earnings Review: Q4 Summary
benzinga.com
Phathom Pharmaceuticals Earnings Review: Q4 Summary

benzinga.com
Phathom Pharmaceuticals Q4 Adj. EPS $(0.08) Beats $(0.38) Estimate, Sales $57.584M Beat $57.050M Est

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.08) per share which beat the

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Phathom Pharma Shows Sales Strength, Targets 2026 Profitability
benzinga.com
Phathom Pharma Shows Sales Strength, Targets 2026 Profitability

Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Drop— AZZ, Northrop Grumman, Immuneering In Focus (UPDATED)
benzinga.com
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Drop— AZZ, Northrop Grumman, Immuneering

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the st

Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
benzinga.com
Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

benzinga.com
Phathom Pharmaceuticals Expects Q4 Net Revenues Of ~$57M-$58M And FY25 Net Revenues Of ~$174.5M-$175

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and c

benzinga.com
Phathom Pharmaceuticals Files For Mixed Shelf Offering; Size Not Disclosed

Common StockPreferred StockDebt SecuritiesWarrantsUnitsWe may offer and sell the securities identifi

Earnings Scheduled For October 30, 2025
benzinga.com
Earnings Scheduled For October 30, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Earnings Scheduled For August 7, 2025

Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday
benzinga.com
Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday

Palo Alto Networks, Take-Two Interactive Software, VF Corp And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Palo Alto Networks, Take-Two Interactive Software, VF Corp And Other Big Stocks Moving Lower In Wedn

benzinga.com
Earnings Scheduled For May 1, 2025

benzinga.com
Earnings Scheduled For March 6, 2025

benzinga.com
Earnings Scheduled For March 7, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

benzinga.com
Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 469 companies hit new 52-week lows.

benzinga.com
Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursda

benzinga.com
Vera Therapeutics, Phathom Pharmaceuticals And Some Other Big Stocks Moving Lower In Wednesday's Pre

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s

benzinga.com
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron A

Biopharma stocks were not immune to the broader market downturn seen for much of 2022.

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022

Upgrades

benzinga.com
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday af

benzinga.com
Nasdaq Turns Positive; Crude Oil Moves Higher

U.S. stocks pared losses midway through trading, with the S&P 500 and Nasdaq Composite turning h

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's trading, 1214 companies set new 52-week lows.

benzinga.com
90 Biggest Movers From Yesterday

Gainers

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 454 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 671 companies achieved new lows for the year.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday morning saw 454 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday's session, 445 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

    On Thursday, 615 stocks hit new 52-week lows.

benzinga.com
65 Biggest Movers From Yesterday

Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after su

benzinga.com
96 Biggest Movers From Friday

Gainers Fuel Tech, Inc (NASDAQ: FTEK) shares climbed 93.6% to close at $0.91 on Friday after the

benzinga.com
77 Biggest Movers From Yesterday

77 Biggest Movers From Yesterday